SEC Form S-1 filed by Firefly Neuroscience Inc.
$AIFF
Computer Software: Prepackaged Software
Technology
Unavailable
Unavailable
Save time and jump to the most important pieces.
TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Dr. Vnook brings over 25 years of experience as a distinguished pharmaceutical executive, serial entrepreneur, CEO and founder of multiple biotech companies and visionary leader with a track record of success in biotechnology and life
SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)
SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)
SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)
Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi
TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that management will participate in the Capital Event Management Conference being held at the JW Marriott Miami in Aventura, Florida on November 22-24, 2024. To schedule a one-on-one investor meeting with management, please contact your representatives at CEM or email KCSA Strategic Communications at [email protected]. About CEMCEM curates exclusive live events and virtual meetings where issuers
TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that the Board of Directors of Firefly granted 557,885 restricted shares (the "Shares") as an inducement grant to David Johnson, the Company's Executive Chairman, pursuant to that certain Employment Agreement (the "Agreement"), by and between the Company and Mr. Johnson. The Shares were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and are subject to the terms and conditions of the Agreemen
10-Q - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
S-1 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi
4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
3 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
3 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)